Rachel Cohrs Zhang

Big news on the Trump administration's exploration of direct-to-consumer drug sales from my colleague @naomikresge in Europe: Roche has been in talks with the government about a pilot project to allow direct-to-consumer drug sales bloomberg.com/news/articles/…

Nice catch by @ReedAbelson & @sangerkatz that CMS is taking its first exploratory steps to change how doctors are paid, including potentially disempowering the American Medical Association nytimes.com/2025/07/21/ups…

News from my colleagues @RobertLangreth & @SamHornblower : Former biotech executive George Tidmarsh will be the FDA's new top drug regulator bloomberg.com/news/articles/…

I am in the middle of two hair cut appointments of both my kids & just got a call from @Kristinapet from Bloomberg News. Kelloggs will be dye free by 2027. Thank you #FoodBabeArmy @SecKennedy #MAHA we did it!

New: Kellogg, the maker of Froot Loops and Apple Jacks, is getting rid of synthetic food dyes by the end of 2027. bloomberg.com/news/articles/…

Latest for @AP: ICE officials will have access to all 79 million Medicaid enrollees' personal data, including addresses and ethnicities, according to an extraordinary agreement signed on Monday. w/ @kimberlykindy apnews.com/article/immigr…

Sen. Richard Blumenthal, a Democrat, just called to end liability protections for vaccine makers during a hearing with people affected by vaccine injury: "I don't really think any industry should be immune from legal responsibility."

A very big study from Denmark generates some reassuring findings about aluminum in childhood vaccines, finding no association between aluminum and development of a number of illnesses, including asthma. statnews.com/2025/07/14/alu…

The definitive story of how Hims found itself in the crosshairs of Big pharma, MAHA, short sellers, regulators, meme-stock investors—and those trying to lose weight. @g0ingmad @devinleonard in the latest @BW bloomberg.com/news/features/…

UnitedHealth quietly sold businesses to private equity firms at the end of last year to avoid missing Wall Street earnings targets. Read my story with @zachmider @ikeswetlitz @jtozz for details about the deals & the unusual accounting decision here $UNH bloomberg.com/news/features/…

In recent months, Hims has been the topic of fervid conversation, disdain and intrigue among any number of groups—pharma companies, short sellers, meme-stock investors, and, of course, those trying to find an affordable way to shed a few pounds. For @BW bloomberg.com/news/features/…

Welch's will cut synthetic dyes from its full lineup of products by early 2026, parent company PIM Brands said, making it the latest American brand to pledge to eliminate the colorants bloomberg.com/news/articles/…

New: ice cream makers are removing artificial dyes by 2028: bloomberg.com/news/articles/…

A new fight is brewing over Medicare drug price negotiations after the Trump administration proposed to consider fixed-dose combo drugs for price cuts with their original drug. news.bloomberglaw.com/health-law-and…

New story! FDA Commissioner Marty Makary has tossed off a lot of neat sounding proposals over his first term. Only one impresses me: the promise to post FDA rejection letters. But linking his new, two-month vouchers to cuts in drug prices? That idea doesn't hold up to basic…

The backlog of delayed grants at @HHSGov has swelled to more than a billion dollars, in wake of DOGE reviews that stalled process Now we're told @ACFHHS is bringing some laid-off staff back temporarily, as officials try to rush awards out door in time cbsnews.com/news/hhs-facin…